Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART

This study has been completed.
Triangle Pharmaceuticals
Gilead Sciences
Bristol-Myers Squibb
Dupont Applied Biosciences
Information provided by:
French National Agency for Research on AIDS and Viral Hepatitis Identifier:
First received: September 12, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted